Ultomiris (ravulizumab-cwvz) and Soliris (eculizumab), two approved treatments for neuromyelitis optica spectrum disorder (NMOSD), may work better than rituximab — a drug not cleared for treating the autoimmune disease but often used off-label — for preventing NMOSD relapses, according to a new review. Still, the study findings…
Discussion
My best friends are my rock. They are my confidants, my vault, and the keepers of my dreams. They drop everything, no matter the hour, no matter the chaos, to be there for me. If loyalty were a sport, they’d be Olympic level. And while I live with neuromyelitis…
A specialized MRI measure used as a proxy of the brain’s waste-clearing system may help monitor disease severity and progression in people with neuromyelitis optica spectrum disorder (NMOSD), according to a new study. NMOSD patients had significantly lower values of the imaging marker, called diffusion tensor imaging (DTI) analysis along…
NMOSD is a progressive autoimmune disease where the immune system mistakenly attacks nerve cells, affecting the nervous system. Learn more about the disease here.
Scientists do not know the exact underlying cause of NMOSD. Self-reactive antibodies that target AQP4 are known to play a major role. Learn more about what causes the disease here.
When the disease affects the optic nerve (optic neuritis), it can result in pain inside the eye and possibly blurry vision or vision loss. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
